References
- Arain M, Haque M, Johal L, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449–461.
- WHO. Adolescent pregnancy; World Health Organization. 2020. www.who.int/news-room/fact-sheets/detail/adolescent-pregnancy
- Hamilton BE, Martin JA, Osterman MJ, et al. Births: final data for 2014. Natl Vital Stat Rep. 2015;64(12):1–64.
- Tejada CA, Triaca LM, da Costa FK, et al. The sociodemographic, behavioral, reproductive, and health factors associated with fertility in Brazil. PLoS One. 2017;12(2):e0171888.
- Oringanje C, Meremikwu MM, Eko H, et al. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev. 2016;2:CD005215.
- WHO. Global health estimates 2015: deaths by cause, age, sex, by country and by region, 2000–2015. Geneva: World Health Organization; 2016.
- Ganchimeg T, Ota E, Morisaki N, WHO Multicountry Survey on Maternal Newborn Health Research Network, et al. Pregnancy and childbirth outcomes among adolescent mothers: a world health organization multicountry study. BJOG. 2014;121(Suppl 1):40–48.
- Gemmill A, Lindberg LD. Short interpregnancy intervals in the United States. Obstet Gynecol. 2013;122(1):64–71.
- Norton M, Chandra-Mouli V, Lane C. Interventions for preventing unintended, rapid repeat pregnancy Among adolescents: a review of the evidence and lessons From High-Quality evaluations. Glob Health Sci Pract. 2017;5(4):547–570.
- Leal MD, Esteves-Pereira AP, Nakamura-Pereira M, et al. Prevalence and risk factors related to preterm birth in Brazil. Reprod Health. 2016;13(Suppl 3):127.
- Chandra-Mouli V, Camacho AV, Michaud PA. WHO guidelines on preventing early pregnancy and poor reproductive outcomes among adolescents in developing countries. J Adolesc Health. 2013;52(5):517–522.
- Pritt NM, Norris AH, Berlan ED. Barriers and facilitators to adolescents’ use of Long-Acting reversible contraceptives. J Pediatr Adolesc Gynecol. 2017;30(1):18–22.
- Borovac-Pinheiro A, Surita FG, D'Annibale A, et al. Adolescent contraception Before and After Pregnancy-Choices and challenges for the future. Rev Bras Ginecol Obstet. 2016;38(11):545–551.
- Farah D, Andrade TRM, Di Bella ZIKJ, et al. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis. Eur J Contracept Reprod Health Care. 2020;25(6):492–501.
- Floyd S. Postpartum contraception options. Obstet Gynecol Clin North Am. 2020;47(3):463–475.
- Eliscu AH, Burstein GR. Updates in contraceptive counseling for adolescents. J Pediatr. 2016;175:22–26.e1.
- Carmo LSMP, Braga GC, Ferriani RA, et al. Timing of Etonogestrel-Releasing implants and growth of breastfed infants: a randomized controlled trial. Obstet Gynecol. 2017;130(1):100–107.
- Barbieri MM, Juliato CRT, Bahamondes L, et al. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol. Reprod Health. 2020;17(1):100.
- Chen MJ, Kim CR, Whitehouse KC, et al. Development, updates, and future directions of the world health organization selected practice recommendations for contraceptive use. Int J Gynaecol Obstet. 2017;136(2):113–119.
- Vieira CS, de Nadai MN, de Melo Pereira do Carmo LS, et al. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception. 2019;100(4):258–263.
- Buckingham P, Moulton JE, Subasinghe AK, et al. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: a systematic review. Acta Obstet Gynecol Scand. 2021;100(4):629–640.
- Griffin L, Hammond C, Liu D, et al. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study. Contraception. 2017;95(6):564–570.
- Tocce K, Sheeder J, Python J, et al. Long-acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting. J Pediatr Adolesc Gynecol. 2012;25(1):59–63.
- Hendrick CE, Cone JN, Cirullo J, et al. Determinants of long-acting reversible contraception (LARC) initial and continued use among adolescents in the United States. Adolescent Res Rev. 2020;5(3):243–279.
- Farah D, Andrade TRM, Di Bella ZIKJ, et al. Pooled incidence of continuation and pregnancy rates of four contraceptive methods in young women: a Meta-analysis. Eur J Contracept Reprod Health Care. 2022;27(2):127–135.
- Bahar YZ, Gold MA. Providing long-acting reversible contraception to adolescents: a review. Clin Obstet Gynecol. 2020;63(3):561–573.
- Galvão RBF, Figueira CO, Borovac-Pinheiro A, et al. Hazards of repeat pregnancy during adolescence: a case-control study. Rev Bras Ginecol Obstet. 2018;40(8):437–443.
- Brunson MR, Klein DA, Olsen CH, et al. Postpartum contraception: initiation and effectiveness in a large universal healthcare system. Am J Obstet Gynecol. 2017;217(1):55.e1–e9.
- Mestad R, Secura G, Allsworth JE, et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project. Contraception. 2011;84(5):493–498.
- Gyllenberg F, Saloranta T, But A, et al. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland. Contraception. 2020;101(6):370–375.
- Berlan E, Mizraji K, Bonny AE. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting. Contraception. 2016;94(1):81–86.
- Peterson AM, Brown A, Savage A, et al. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. Eur J Contracept Reprod Health Care. 2019;24(6):475–479.
- Agostini A, Godard C, Laurendeau C, et al. Two year continuation rates of contraceptive methods in France: a cohort study from the french national health insurance database. Eur J Contracept Reprod Health Care. 2018;23(6):421–426.
- Gurtcheff SE, Turok DK, Stoddard G, et al. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet Gynecol. 2011;117(5):1114–1121.
- Francis JKR, Gold MA. Long-Acting reversible contraception for adolescents: a review. JAMA Pediatr. 2017;171(7):694–701.
- Makins A, Cameron S. Post pregnancy contraception. Best Pract Res Clin Obstet Gynaecol. 2020;66:41–54.
- Bryant AG, Bauer AE, Stuart GS, et al. Etonogestrel-Releasing contraceptive implant for postpartum adolescents: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2017;30(3):389–394.
- Barbieri MM, Herculano T, Dantas Silva A, et al. Acceptability of ENG-releasing subdermal implants before discharge in Brazilian young women during the COVID-19 pandemic. Int J Gynaecol Obstet. 2021;154(1):106–112.
- Mogeni R, Mokua JA, Mwaliko E, et al. Predictors of contraceptive implant uptake in the immediate postpartum period: a cross-sectional study. Eur J Contracept Reprod Health Care. 2019;24(6):438–443.
- Barbieri MM, Juliato CRT, Surita FG. Provision and guidance for postpartum Contraception - Ensuring reproductive rights during times of crises. Rev Bras Ginecol Obstet. 2021;43(4):247–249.
- Linet T, Lévy-Bachelot L, Farge G, et al. Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France. Eur J Contracept Reprod Health Care. 2021;26(4):303–311.
- Bahamondes L, Makuch MY. Family planning: an essential health activity in the pandemic of SARS-CoV-2. Eur J Contracept Reprod Health Care. 2020;25(4):319–320.